Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $1.9 Million - $2.48 Million
-21,754 Closed
0 $0
Q1 2022

Sep 21, 2023

BUY
$94.19 - $124.49 $565,234 - $747,064
6,001 Added 40.2%
20,930 $2.32 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $642,846 - $849,644
6,825 Added 45.72%
21,754 $2.32 Million
Q4 2021

Sep 21, 2023

BUY
$119.57 - $139.07 $301,077 - $350,178
2,518 Added 20.29%
14,929 $1.91 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $301,077 - $350,178
2,518 Added 20.29%
14,929 $1.91 Million
Q3 2021

Sep 21, 2023

SELL
$109.17 - $142.35 $1.38 Million - $1.8 Million
-12,610 Reduced 50.4%
12,411 $1.65 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $1.35 Million - $1.77 Million
12,411 New
12,411 $1.65 Million
Q1 2021

May 14, 2021

SELL
$101.51 - $125.27 $2.54 Million - $3.13 Million
-25,021 Closed
0 $0
Q4 2020

Sep 21, 2023

BUY
$85.88 - $105.36 $2.15 Million - $2.64 Million
25,021 New
25,021 $2.6 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $1.08 Million - $1.32 Million
12,521 Added 100.17%
25,021 $2.6 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $2.73 Million - $3.47 Million
-37,500 Reduced 75.0%
12,500 $1.07 Million
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $1.85 Million - $3.15 Million
50,000 New
50,000 $2.6 Million
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $888,336 - $1.23 Million
-22,627 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $675,189 - $993,777
22,627 New
22,627 $918,000
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $353,056 - $400,840
-8,800 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$38.72 - $42.52 $340,736 - $374,176
8,800 New
8,800 $369,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.